BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7012490)

  • 1. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
    Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL; Hammer C
    J Med; 1981; 12(6):447-53. PubMed ID: 7033427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Squamous cell carcinoma of the palatine tonsils. Effect on the immune system in man].
    Mang WL
    Fortschr Med; 1984 Sep; 102(35):867-71. PubMed ID: 6237969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunofluorescence of oral swabs--a new method for early recognition of recurrencies in patients with tonsillar carcinoma? (author's transl)].
    Mang WL; Hammer C
    Laryngol Rhinol Otol (Stuttg); 1981 Jul; 60(7):385-6. PubMed ID: 6178920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.
    Gupta RK; Morton DL
    Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-squamous tumor antibodies in patients with squamous cell carcinoma.
    Sofen H; O'Toole C
    Cancer Res; 1978 Jan; 38(1):199-203. PubMed ID: 338144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
    Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
    Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
    Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
    Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to detect circulating IgG or IgM antibodies to basal cell carcinoma by immunofluorescence.
    Blewitt RW; Aparicio SR; Burrow HM; Rowell NR; Rowell RM
    Acta Derm Venereol; 1978; 58(1):82-3. PubMed ID: 75642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
    Cronin WJ; Dorsett BH; Ioachim HL
    Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
    Kutteh WH; Doellgast GJ
    J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies in patients with cervicouterine carcinoma].
    Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
    Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries].
    Stankus P; Gazárek F
    Cesk Gynekol; 1983 Jun; 48(5):332-8. PubMed ID: 6352065
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological studies on patients with tonsillar carcinoma: progress?].
    Mang WL; Hammer C; Lersch C; Woldemar I
    Strahlenther Onkol; 1987 Aug; 163(8):491-9. PubMed ID: 2957807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bound IgG, IgM, IgA and complement in the epidermis of the growth zone of skin tumors].
    Beletskaia LV; Berenbeĭn BA; Silagadze DG; Ezhov NIa
    Vestn Dermatol Venerol; 1981 Jan; (1):13-6. PubMed ID: 7210863
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response to embryonal carcinoma cells in syngeneic mice.
    Damonneville M; Morello D; Gachelin G; Stanislawski M
    Eur J Immunol; 1979 Dec; 9(12):932-7. PubMed ID: 549777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface immunoglobulins of tonsil lymphocytes.
    Antoni F; Jobbágy A; Puskás M
    Acta Microbiol Acad Sci Hung; 1981; 28(1):83-9. PubMed ID: 7020356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients.
    Warnakulasuriya S; Soussi T; Maher R; Johnson N; Tavassoli M
    J Pathol; 2000 Sep; 192(1):52-7. PubMed ID: 10951400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
    Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
    J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.